SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis
Kaname Akamata(University of Tokyo Hospital), John Varga(Michigan Medicine)
Cited by 108
Related Papers
Systemic sclerosis: a prototypic multisystem fibrotic disorder
|Journal of Clinical Investigation|2007|1.1k
Rosiglitazone Abrogates Bleomycin-Induced Scleroderma and Blocks Profibrotic Responses Through Peroxisome Proliferator-Activated Receptor-γ
|American Journal Of Pathology|2009|227
Targeted Disruption of TGF-β/Smad3 Signaling Modulates Skin Fibrosis in a Mouse Model of Scleroderma
|American Journal Of Pathology|2004|213
Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: A novel mouse model for scleroderma?
|Arthritis & Rheumatism|2011|211